ReportGem ReportGem

U.S. COMPANY FILING

BRISTOL MYERS SQUIBB CO — Form 10-Q filed 2025-10-30

Filed: 2025-10-30Company: BRISTOL MYERS SQUIBB COTicker: BMYExchange: NYSEForm: 10-QReport period: 2025-09-30SEC accession: 0000014272-25-000149Event: earningsMateriality: 85

Filing text preview

Bristol-Myers Squibb reported Q3 2025 revenues of $12.22 billion, up 3% year-over-year, with GAAP EPS of $1.08, up from $0.60. Nine-month revenues were $35.69 billion, down 1%. The company continues its strategic productivity initiative, expecting ~$2.0 billion annual savings by 2027. Impairments were recorded for alnuctamab and Inrebic, and the 2023 restructuring plan was expanded.

This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.

Open filing record

Related research and intelligence

Official SEC filing2025-10-3010-Q2026-07-30 · 10-Q8-K2026-07-30 · 8-K10-Q2026-04-30 · 10-Q8-K2026-04-30 · 8-K10-K2026-02-11 · 10-K8-K2026-02-05 · 8-K